Surviving Cutaneous Melanoma: A Clinical Review of Follow-up Practices, Surveillance, and Management of Recurrence

Amy A. Mrazek, Celia Chao

Research output: Contribution to journalReview article

18 Scopus citations


The number of melanoma survivors in the United States continues to steadily increase 2.6% per year, while death rates have remained stable over time. Although controversy exists regarding optimal surveillance strategies, recommendations for clinical monitoring are based on tumor stage, tumor phenotype, likelihood of recurrence, prognosis, risk factors, psychosocial impact of disease, and patient well-being. Management guidelines for recurrent disease depend on the type of recurrence: local, satellite/in-transit, regional, or distant metastasis. This article is a current review of the literature concerning melanoma survivorship.

Original languageEnglish (US)
Pages (from-to)989-1002
Number of pages14
JournalSurgical Clinics of North America
Issue number5
StatePublished - Oct 1 2014



  • Management of recurrence
  • Melanoma survivorship
  • Surveillance and follow-up
  • Survival prognosis

ASJC Scopus subject areas

  • Surgery

Cite this